The estimated Net Worth of Securities Usa Llc Mizuho is at least $7.41 Million dollars as of 5 April 2021. Securities Mizuho owns over 35,000 units of KBL Merger IV stock worth over $2,630,978 and over the last 5 years Securities sold KBLM stock worth over $4,779,773.
Sign up
Securities Mizuho KBLM stock SEC Form 4 insiders trading
Securities has made over 4 trades of the KBL Merger IV stock since 2019, according to the Form 4 filled with the SEC. Most recently Securities sold 35,000 units of KBLM stock worth $368,550 on 5 April 2021.
The largest trade Securities's ever made was selling 200,000 units of KBL Merger IV stock on 12 August 2019 worth over $2,096,000. On average, Securities trades about 114,087 units every 151 days since 2019. As of 5 April 2021 Securities still owns at least 527,250 units of KBL Merger IV stock.
You can see the complete history of Securities Mizuho stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Securities Mizuho's mailing address?
Securities's mailing address filed with the SEC is 1271 AVENUE OF THE AMERICAS, FLOORS - 2,3,4,18,19, NEW YORK, NY, 10020.
Insiders trading at KBL Merger IV
Over the last 7 years, insiders at KBL Merger IV have traded over $12,807,331 worth of KBL Merger IV stock. The most active insiders traders include Asset Management Partners I..., Asset Management Llp Oxford, and Securities Usa Llc Mizuho. On average, KBL Merger IV executives and independent directors trade stock every 52 days with the average trade being worth of $380,652. The most recent stock trade was executed by Asset Management Llp Oxford on 9 October 2019, trading 699,900 units of KBLM stock currently worth $7,355,949.
What does KBL Merger IV do?
KBL Merger Corp. IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal reimbursement risk the firm focuses on retail healthcare, wellness and preventative care. In devices and diagnostics the firm focuses on medical devices, diagnostics, genetic testing and lab tools. The firm typically invests in firms located in the United States. The firm seeks to invest in firms with valuation between $200 million to $700 million and EBITDA between $20 million to $70 million. The firms invest in firms with enterprise value $200 million to $700 million. The firm seeks to take majority stakes. KBL Merger Corp. IV was founded in 2016 and is New York, New York with an additional office in Newark, Delaware.
What does KBL Merger IV's logo look like?
Complete history of Securities Mizuho stock trades at AGBA Acquisition and KBL Merger IV
KBL Merger IV executives and stock owners
KBL Merger IV executives and other stock owners filed with the SEC include:
-
Shoshana Shendelman,
Director -
Donald McGovern,
Director -
Larry Gold,
Director -
Richard Barker,
Director -
Jonathan Rothbard,
Chief Scientific Officer -
James Woody,
Chief Executive Officer, Director -
Lawrence Steinman,
Co-Executive Chairmen of the Board -
Marc Feldmann,
Co-Executive Chairman of the Board -
Asset Management Llp Oxford,
10% owner -
Asset Management Lpweiss An...,
-
Securities Usa Llc Mizuho,
10% owner -
Asset Management Partners I...,
10% owner